236 related articles for article (PubMed ID: 19483087)
1. Identification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domains.
Corcoran CA; Montalbano J; Sun H; He Q; Huang Y; Sheikh MS
J Biol Chem; 2009 Aug; 284(33):21955-21970. PubMed ID: 19483087
[TBL] [Abstract][Full Text] [Related]
2. Identification of Pirh2D, an Additional Novel Isoform of Pirh2 Ubiquitin Ligase.
Shi J; Huang Y; Sheikh MS
Mol Cell Pharmacol; 2010; 2(1):21-23. PubMed ID: 20357911
[TBL] [Abstract][Full Text] [Related]
3. Identification of Pirh2E and Pirh2F, two additional novel isoforms of Pirh2 ubiquitin ligase from human hepatocellular liver carcinoma cell line.
Dong L; Liu Y; Qiu Y; Peng B; Yin J; Liu W; He X
Biomed Mater Eng; 2012; 22(1-3):89-95. PubMed ID: 22766706
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2.
Shloush J; Vlassov JE; Engson I; Duan S; Saridakis V; Dhe-Paganon S; Raught B; Sheng Y; Arrowsmith CH
J Biol Chem; 2011 Feb; 286(6):4796-808. PubMed ID: 21084285
[TBL] [Abstract][Full Text] [Related]
5. Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.
Wang L; He G; Zhang P; Wang X; Jiang M; Yu L
Mol Biol Rep; 2011 Jan; 38(1):229-36. PubMed ID: 20333547
[TBL] [Abstract][Full Text] [Related]
6. PRPF8 controls alternative splicing of PIRH2 to modulate the p53 pathway and survival of human ESCs.
Sun Y; Zhang L; Fang Z; Liu D; Shao M; Liu Y; Liao B; Jin Y
J Cell Physiol; 2023 Aug; 238(8):1909-1920. PubMed ID: 37357506
[TBL] [Abstract][Full Text] [Related]
7. Pirh2 RING-finger E3 ubiquitin ligase: its role in tumorigenesis and cancer therapy.
Jung YS; Qian Y; Chen X
FEBS Lett; 2012 May; 586(10):1397-402. PubMed ID: 22673504
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of Pirh2-mediated p53 ubiquitylation.
Sheng Y; Laister RC; Lemak A; Wu B; Tai E; Duan S; Lukin J; Sunnerhagen M; Srisailam S; Karra M; Benchimol S; Arrowsmith CH
Nat Struct Mol Biol; 2008 Dec; 15(12):1334-42. PubMed ID: 19043414
[TBL] [Abstract][Full Text] [Related]
9. Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4.
Fan C; Wang X
Cell Cycle; 2017 Apr; 16(7):660-664. PubMed ID: 28166445
[TBL] [Abstract][Full Text] [Related]
10. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.
Leng RP; Lin Y; Ma W; Wu H; Lemmers B; Chung S; Parant JM; Lozano G; Hakem R; Benchimol S
Cell; 2003 Mar; 112(6):779-91. PubMed ID: 12654245
[TBL] [Abstract][Full Text] [Related]
11. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.
Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA
Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800
[TBL] [Abstract][Full Text] [Related]
12. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination.
Ma J; Martin JD; Zhang H; Auger KR; Ho TF; Kirkpatrick RB; Grooms MH; Johanson KO; Tummino PJ; Copeland RA; Lai Z
Biochemistry; 2006 Aug; 45(30):9238-45. PubMed ID: 16866370
[TBL] [Abstract][Full Text] [Related]
13. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.
Fang S; Jensen JP; Ludwig RL; Vousden KH; Weissman AM
J Biol Chem; 2000 Mar; 275(12):8945-51. PubMed ID: 10722742
[TBL] [Abstract][Full Text] [Related]
14. Dual-site regulation of MDM2 E3-ubiquitin ligase activity.
Wallace M; Worrall E; Pettersson S; Hupp TR; Ball KL
Mol Cell; 2006 Jul; 23(2):251-63. PubMed ID: 16857591
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
16. PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53.
Zheng G; Ning J; Yang YC
Biochem Biophys Res Commun; 2007 Dec; 364(2):344-50. PubMed ID: 17950244
[TBL] [Abstract][Full Text] [Related]
17. A site-directed mutagenesis study of the MdmX RING domain.
Egorova O; Mis M; Sheng Y
Biochem Biophys Res Commun; 2014 May; 447(4):696-701. PubMed ID: 24755078
[TBL] [Abstract][Full Text] [Related]
18. Critical contribution of the MDM2 acidic domain to p53 ubiquitination.
Kawai H; Wiederschain D; Yuan ZM
Mol Cell Biol; 2003 Jul; 23(14):4939-47. PubMed ID: 12832479
[TBL] [Abstract][Full Text] [Related]
19. MDM2 protein-mediated ubiquitination of numb protein: identification of a second physiological substrate of MDM2 that employs a dual-site docking mechanism.
Sczaniecka M; Gladstone K; Pettersson S; McLaren L; Huart AS; Wallace M
J Biol Chem; 2012 Apr; 287(17):14052-68. PubMed ID: 22337874
[TBL] [Abstract][Full Text] [Related]
20. Autoactivation of the MDM2 E3 ligase by intramolecular interaction.
Cheng Q; Song T; Chen L; Chen J
Mol Cell Biol; 2014 Aug; 34(15):2800-10. PubMed ID: 24842904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]